University of Texas Southwestern Harold C. Simmons Comprehensive Cancer Center — Dallas, Texas

University of Texas Southwestern Harold C. Simmons Comprehensive Cancer Center is a clinical research site located in Dallas, Texas, United States 75390.

Crixeo Health Trust Score: 68/100 (FAIR). This profile has not yet been claimed by the site owner.

University of Texas Southwestern Harold C. Simmons Comprehensive Cancer Center has participated in 3 clinical trials with 1 currently active.

Therapeutic areas: Metastatic Breast Cancer, Cholangiocarcinoma, FGFR2 Fusion.

Sponsors: Gilead Sciences, TransThera Sciences (Nanjing), Inc., K36 Therapeutics, Inc..

Sponsor Feasibility Report

Trust Score: 68/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for University of Texas Southwestern Harold C. Simmons Comprehensive Cancer Center?

University of Texas Southwestern Harold C. Simmons Comprehensive Cancer Center has a Crixeo Trust Score of 68/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has University of Texas Southwestern Harold C. Simmons Comprehensive Cancer Center conducted?

University of Texas Southwestern Harold C. Simmons Comprehensive Cancer Center has 3 clinical trials on record, with 1 currently active. Their work covers Metastatic Breast Cancer, Cholangiocarcinoma, FGFR2 Fusion.

Is University of Texas Southwestern Harold C. Simmons Comprehensive Cancer Center accredited by Crixeo Health?

University of Texas Southwestern Harold C. Simmons Comprehensive Cancer Center has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about University of Texas Southwestern Harold C. Simmons Comprehensive Cancer Center?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.